In a report released today, Vincent Andrews from Morgan Stanley maintained a Buy rating on Eastman Chemical, with a price target of $115.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Vincent Andrews has given his Buy rating due to a combination of factors influencing Eastman Chemical’s financial outlook. Despite revising the earnings per share (EPS) estimates for the second quarter of 2025 slightly downward, the projections for 2026 and 2027 remain strong and above consensus expectations. This indicates a positive long-term growth trajectory for the company.
Additionally, while there are some headwinds in the Chemical Intermediates segment due to unexpected costs and macroeconomic challenges, these are partially offset by the easing of tariff-related impacts. The company’s ability to navigate these challenges and maintain robust EBIT forecasts for the coming years supports the Buy recommendation, suggesting confidence in Eastman Chemical’s resilience and potential for future profitability.
In another report released on July 9, UBS also maintained a Buy rating on the stock with a $101.00 price target.